
Sign up to save your podcasts
Or


Join us for an exciting discussion led by Dr Hemal Gada, an Interventional Cardiologist from UPMC,Pennsylvania, and Dr. Gilbert Tang, a Cardiac Surgeon from Mount Sinai in NY. The conversation will explore how the evolving TAVR landscape shapes Aortic Stenosis interventions. From the early days to the present, a significant number of patients have been treated, generating a wealth of data on efficiencies, PVL, Hemodynamic impact, and clinical results. What will the data reveal? Will we see a 'TAVR Tsunami' of patients or a more gradual increase in returning patients? Are there any predictors that can help us identify the right patient? What role does Neosinus flow and thrombosis play in this context?
By SHJoin us for an exciting discussion led by Dr Hemal Gada, an Interventional Cardiologist from UPMC,Pennsylvania, and Dr. Gilbert Tang, a Cardiac Surgeon from Mount Sinai in NY. The conversation will explore how the evolving TAVR landscape shapes Aortic Stenosis interventions. From the early days to the present, a significant number of patients have been treated, generating a wealth of data on efficiencies, PVL, Hemodynamic impact, and clinical results. What will the data reveal? Will we see a 'TAVR Tsunami' of patients or a more gradual increase in returning patients? Are there any predictors that can help us identify the right patient? What role does Neosinus flow and thrombosis play in this context?